Bender Robert & Associates Chimerix Inc Transaction History

Bender Robert & Associates

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	BUY	$1.19 - $2.09 $12,624 - $22,172	10,609 New	10,609 $13,000
Q2 2022 Jul 19, 2022	BUY	$1.34 - $5.34 $14,216 - $56,652	10,609 New	10,609 $22,000
Q2 2021 Jul 16, 2021	SELL	$7.54 - $9.79 $75,400 - $97,899	-10,000 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$4.76 - $11.25 $47,600 - $112,500	10,000 New	10,000 $96,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Bender Robert & Associates, based on Form 13F filings with the SEC.

Stay updated on Bender Robert & Associates with notifications on news.